Clopidogrel Dosing: Once Daily Administration
Clopidogrel is administered once daily at a maintenance dose of 75 mg, not twice daily. 1, 2
Standard Maintenance Dosing
- The FDA-approved maintenance dose is 75 mg once daily for all indications including acute coronary syndrome, recent MI, recent stroke, or established peripheral arterial disease 2
- This once-daily regimen applies universally regardless of patient age, gender, weight, or race, with no dose adjustment required 3
- The 75 mg once daily dose should be continued indefinitely after the initial loading phase 1
Loading Dose Strategies (Initial Treatment Only)
For patients initiating clopidogrel therapy, loading doses vary by clinical scenario but are always followed by the same 75 mg daily maintenance:
- Acute coronary syndrome (ACS): 600 mg loading dose, then 75 mg once daily 1
- Post-fibrinolytic therapy: 300 mg loading dose if given within 24 hours; 600 mg if given more than 24 hours after fibrinolysis 1
- Stable coronary disease: May initiate at 75 mg daily without loading dose, though this delays antiplatelet effect by several days 2
Contrast with Ticagrelor (Twice-Daily Agent)
It is critical not to confuse clopidogrel's dosing with ticagrelor, which requires twice-daily administration:
- Ticagrelor is dosed at 90 mg twice daily (not once daily) for maintenance therapy 1, 4
- Ticagrelor's twice-daily requirement stems from its 12-hour half-life and reversible P2Y12 inhibition 4
- Clopidogrel's once-daily dosing may improve adherence compared to ticagrelor's twice-daily regimen 5
Duration of Therapy
- After stent placement for ACS: Continue clopidogrel 75 mg daily for at least 12 months 1
- After drug-eluting stent for non-ACS: Continue 75 mg daily for at least 12 months if bleeding risk is not prohibitive 1
- After bare-metal stent for non-ACS: Minimum 1 month, ideally up to 12 months (or minimum 2 weeks if high bleeding risk) 1
Common Pitfall to Avoid
Do not confuse clopidogrel with ticagrelor dosing. Clopidogrel is always once daily at 75 mg maintenance, while ticagrelor requires 90 mg twice daily. This distinction is clinically important for patient counseling and medication reconciliation 1, 4.